KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,769 | -80.9% | 661 | -75.6% | 0.00% | -100.0% |
| Q2 2023 | $586,579 | +11.4% | 2,705 | -6.7% | 0.00% | 0.0% |
| Q1 2023 | $526,574 | -25.6% | 2,899 | -19.6% | 0.00% | 0.0% |
| Q4 2022 | $708,186 | -12.2% | 3,604 | +0.5% | 0.00% | -50.0% |
| Q3 2022 | $807,000 | +45.7% | 3,585 | -18.2% | 0.00% | +100.0% |
| Q2 2022 | $554,000 | +601.3% | 4,382 | +606.8% | 0.00% | – |
| Q1 2022 | $79,000 | +3.9% | 620 | +6.9% | 0.00% | – |
| Q4 2021 | $76,000 | +7.0% | 580 | 0.0% | 0.00% | – |
| Q3 2021 | $71,000 | -21.1% | 580 | -26.1% | 0.00% | – |
| Q2 2021 | $90,000 | -68.3% | 785 | -66.8% | 0.00% | -100.0% |
| Q1 2021 | $284,000 | -32.2% | 2,365 | -42.6% | 0.00% | 0.0% |
| Q4 2020 | $419,000 | -1.4% | 4,121 | -25.0% | 0.00% | 0.0% |
| Q3 2020 | $425,000 | +193.1% | 5,496 | +323.4% | 0.00% | – |
| Q2 2020 | $145,000 | +90.8% | 1,298 | +23.7% | 0.00% | – |
| Q1 2020 | $76,000 | +162.1% | 1,049 | +172.5% | 0.00% | – |
| Q4 2019 | $29,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |